Volume 2, Issue 2 (11-2020)
pbp 2020, 2(2): 1-13 |
Back to browse issues page
Fatehalrahman F. Magbool * 
1, Elamin Ibrahim Elnima2 , Shayoub M. E2 , Elnazeer I. Hamedelniel3 , Abdrhman Mahmoud Gamil4 , Mohamed E. Adam5 , Zuheir Osman2
1, Elamin Ibrahim Elnima2 , Shayoub M. E2 , Elnazeer I. Hamedelniel3 , Abdrhman Mahmoud Gamil4 , Mohamed E. Adam5 , Zuheir Osman2
1- Department of Pharmaceutics and Pharmaceutical Technology, Khartoum University, P.O. Box 1998, Sudan , fmagbool@yahoo.com
2- Department of Pharmaceutics and Pharmaceutical Technology, Khartoum University, P.O. Box 1998, Sudan
3- Associate professor of Pharmaceutics, Faculty of Pharmacy, Omdurman Islamic University, Sudan
4- Associate professor of Pharmaceutics, Faculty of Pharmacy, Al-Neelain University, Sudan
5- Department of Chemistry, Faculty of Pharmacy, University of Khartoum, P.O. Box 1998, Khartoum, Sudan
2- Department of Pharmaceutics and Pharmaceutical Technology, Khartoum University, P.O. Box 1998, Sudan
3- Associate professor of Pharmaceutics, Faculty of Pharmacy, Omdurman Islamic University, Sudan
4- Associate professor of Pharmaceutics, Faculty of Pharmacy, Al-Neelain University, Sudan
5- Department of Chemistry, Faculty of Pharmacy, University of Khartoum, P.O. Box 1998, Khartoum, Sudan
Abstract: (2176 Views)
The objective of the study is to design, formulate and evaluate an oral gel containing Q. infectoria galls extract for its anti-Candida activity. The gel formulation was designed by using carbapol 940 and xanthan gum as gel forming polymers, propylene glycol, methyl paraben, propyl paraben and required amount of distilled water. The pH was maintained by drop wise addition of Tri-ethanolamine. Eight different gel formulations (F1 to F8) were prepared by dispersion method, using different concentrations of carbopol 940 for carbopol 940-based oral gels (F1and F2), and combined with xanthan gum as secondary gelling polymer for combined polymer-based formulations (F3-F8) have been prepared to study the individual effect of two polymers as well as polymer concentrations, and they were evaluated using official and non-official experiments including organoleptic properties, pH, spreadability, extrudability and viscosity, in vitro release and drug content uniformity. The stability study for the developed gel formulation was done as per ICH guidelines and antifungal activity was evaluated by paper disc diffusion method. The overall pharmaceutical acceptability were satisfactory for the developed oral gels regarding chemical and physical investigations. The viscosity of oral gels was significantly (P<0.05) affected by both of polymer concentration and polymer type, also the developed oral gel formulations exhibited antifungal activity against C. albicans, it was observed that the biological activity of prepared oral gels significantly (P=0.03) increases with decreasing polymers concentration. The accelerated stability testing indicated that all formulations showed a good stability, thus providing a safe and stable gel delivery system. The pharmaceutical evaluations and in vitro results showed that oral gel formulations can be a potential candidate for the delivery of Q. infectoria galls ethanolic extract to the oral cavity, with better in vitro characteristics, physicochemical properties and pharmacological activity, using carbopol 940 alone and in combination with xanthan gum as drug carriers.
Keywords: Q. infectoria galls, anti-Candida activity, Oral gel, Physicochemical properties, Carbopol 940, Xanthan gum.
Type of Study: Research |
Received: 2020/06/10 | Accepted: 2020/06/29 | Published: 2020/08/16
Received: 2020/06/10 | Accepted: 2020/06/29 | Published: 2020/08/16
References
1. Paderni C, Compilato D, Giannola LI, Campisi G, 2012. Oral local drug delivery and new perspectives in oral drug formulation. Oral Surg Oral Med Oral Pathol Oral Radiol, 114:e25-e34.
2. Chun M K, Kwak B T and Choi H K 2003 Arch. Pharm.Res. 2611 973
3. Tamburic S and Craig D Q M 1995 Pharm. Sci. 1 107
4. Tamburic S and Craig D Q M 1995 J. Control. Rel. 32 59
5. Dinte E and Leucuta S E 2004 Farmacia LII 5 13
6. Dumitriu, S., M. Dumitriu and G. Teaca, 1990, Bioactive polymers 65: Studies of cross-linked xanthan hydrogels as supports in drug retardation, Clin. Mater. 6, 265-276.
7. Dumitriu, S. and E. Chornet, 1997, Immobilization of xylanase in chitosan-xanthan hydrogels, Biotech. Prog. 13, 539-545.
8. Iseki, T., M. Takahashi, H. Hattori, T. Hatakeyama and H. Hatakeyama, 2001, Viscoelastic properties of xanthan gum hydrogels annealed in the sol state, Food Hydrocolloids 15, 503-506.
9. Alupei, I.C., M. Popa, M. Hamcerencu and M.J.M. Abadie, 2002,Superabsorbant hydrogels based on xanthan and poly (vinylalchol). 1. The study of the swelling properties, Eur. Polym. J.38, 2313-2320.
10. Talukdar, M.M., G.V. Mooter, P. Augustijins, T. Tjandra-Maga, N. Verbeke and R. Kinget, 1998, In vivo evaluation of xanthan gum as a potential excipient for oral controlled-release matrix tablet formation, Intern. J. Pharm. 169, 105-113.
11. Sukhdev. S. H; Suman. P. S. K; Gennaro. L and Dev. D. R. Extraction technologies for medicinal and aromatic plants. United Nation Industrial Development Organization and the International Center for Science and High Technology, 2008; 116.
12. Afaf, A. and Ramadan, A. (2008). Formulation and evaluation of bioadhesive gel containing miconazole nitrate, Applied Sci.Res., 4, 9, 1052-1065.
13. Farhan, A.; Mohd, A.; Zeenat, K.; Roop, K. and Mushir Ali. (2008). Development and in vitro evaluation of an acid buffering bioadhesive vaginal gel for mixed vaginal infection,Acta Pharm. 58, 407-419.
14. Kaur, L.P.; Guleri, T.K.; Topical gel: A Recent Approach For Novel Drug delivery. Asian journal of biomedical and Pharmaceutical Sciences 2013, 3, 1-5.
15. Covington, A. K.; Bates, R. G.; Durst, R. A. (1985). Definitions of pH scales, standard reference values, measurement of pH, and related terminology. Pure Appl. Chem.1985; 57(3):531–542.
16. Vishnu Vardhan Reddy Beeram (2010). Formulation, development and evaluation of cefixime oral medicated jelly. Indian Journal of Pharmaceutical Sciences. 78(2): 68-73.
17. Mishra U.S., Murthy P.N., Pasa G., Nayak R.K. Formulation and evaluation of herbal gel containing methanolic extract of Ziziphus Xylopyrus. IJBPR.2011: 1(4): 207-218.
18. Kumar L , Verma R, International Journal of Drug Delivery , 2010, 2, 58-63.
19. Panigrahi L, Ghosal SK, Pattnaik S, Maharana L, Barik BB; Effect of permeation enhancers on the Release and permeation kinetics of Lincomycin Hydrochloride gel formulations through Mouse skin. Indian J Pharm Sci., 2006; 205-211.
20. Das, K.; Dang, R.; Machale, M. U.; Formulation and Evaluation of A Novel Herbal Gel Of Stevia Extract. Iranian Journal of Dermatology 2010, 12, 117-122.
21. Sethi P D, Quantitative Analysis of Drugs in Pharmaceutical Formulations, 3rd ed, 2008, CBS Publishers.
22. Negi, A.; Sharma, M.; Singh, M.; Formulation and Evaluation of an Herbal Anti-Inflammatory Gel Containing Eupatorium Leaves Extract. Journal of Pharmacognosy and Phytochemistry 2012, 1, 112-117.
23. United States Pharmacopoeia, 23 NF 18, 1995, Asian Edition, 2049.
24. National Committee for Clinical Laboratory Standards (NCCLS) (1999). Performance standards for antimicrobial susceptibility testing; ninth informational supplement. Wayne, Pensilvania document M100-S9, Vol.19.
25. ICH guidelines, Stability testing of new drug substances and products, 27th October, 1993.
26. Carl AB, Edward RA, David EB, Tietz NW, Text book of clinical chemistry and molecular diagnostics, 4th rev. ed., W.B Saunders Philadelphia, 2001.
27. Yong CS, Choi JS, Quan QZ, Rhee JD, Kim CK, Lim SJ, Kim KM and Choi HG. Effect of sodium chloride on the gelation temperature, gel strength and bioadhesive force of poloxamer gels containing diclofenac sodium. Int. J. Pharm. (2001) 226: 195-205.
28. Shojaei AH, Buccal mucosa as a route for systemic drug delivery: a review, J. Pharm. Pharmaceut. Sci., 1(1) (1998) 15-30.
29. M.S.Wani, S.R. Parakh, M.H. Dehghan, S.A. Polshettiwar, V.V. Pande, V.V. Chopade, Current Status In Buccal Drug Delivery. www.pharmainfo.net as on 28 April (2007).
30. Contreras, M. D. and Sanchez, R. (2002). Application of a factorial design to the study of the flow behavior, spreadability and transperancy of a carbopol ETD 2020 gel. Part II, International Journal of Pharmaceutics, 234: 149-157.
31. Songkro S, Rajatasereekul N, Cheewasrirungrueng N. In vitro studies of mucoadhesiveness and release of nicotinamide oral gels prepared from bioadhesive polymers. World Academy of Science, Engineering and Technology (WASET). 2009;55:113-120.
32. Macedo T, Block LH, Shukla AJ. Release of tolmetin from carbomer gel systems. Drug Dev Ind Pharm. 1993;19:887-902.
33. Lubna A., Hala T., Yehia I. An investigation release and rheological al properties of miconazole nitrate from emulgel. Iraqi J Pharm Sci, 2009; 18(2):26-31.
34. Xin C, Lihong W, Qiuyuan L, Hongzhuo L. Injectable long-term control-released in situ gels of hydrochloric thiothixene for the treatment of schizophrenia: preparation, in vitro and in vivo evaluation. Int J Pharm 2014;469(1):23-30.
35. Prakash, P. R., Rao, N. R., and Chowdary, S. (2010). Formulation, evaluation and anti-inflammatory activity of topical etoricoxib gel. Asian J. of Pharm. and Clinical Res, 3, 126.
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |